Literature DB >> 9679326

Nuclear translocation of tissue type transglutaminase during sphingosine-induced cell death: a novel aspect of the enzyme with DNA hydrolytic activity.

Y Takeuchi1, H Ohashi, P J Birckbichler, T Ikejima.   

Abstract

Tissue type (type 2) transglutaminase (TGase, EC 2.3.2.13) has been implicated in various cellular processes including cell death. In order to better understand the role of this enzyme in cell death, human melanocytic A375-S2 cells were treated with sphingosine, a cell-signaling mediator. During the rapid onset of cytotoxicity caused by this lipidic agent, tissue TGase was translocated from the cytoplasm to the cell nuclei. This observation was further remarked in relevance to its previously undescribed activity for DNA degradation. The DNA hydrolytic activity associated with tissue TGase was dependent on Mg2+ in contrast to the Ca2+ requirement for the classical cross-linking activity of TGase, and was inhibited by Zn2+. Based on the results shown here, we propose a novel aspect of tissue TGase in cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679326     DOI: 10.1515/znc-1998-5-609

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  11 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Authors:  Matthew L Fisher; Jeffrey W Keillor; Wen Xu; Richard L Eckert; Candace Kerr
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

3.  Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.

Authors:  Soner Gundemir; Gozde Colak; Julianne Feola; Richard Blouin; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2012-10-17

Review 4.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

5.  Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.

Authors:  D R D'Souza; J Wei; Q Shao; M D Hebert; S H Subramony; P J S Vig
Journal:  Neurosci Lett       Date:  2006-10-11       Impact factor: 3.046

Review 6.  Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.

Authors:  Kajal Kanchan; Mónika Fuxreiter; László Fésüs
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

7.  Transglutaminase-catalyzed incorporation of polyamines masks the DNA-binding region of the transcription factor Relish.

Authors:  Kouki Maki; Toshio Shibata; Shun-Ichiro Kawabata
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

8.  Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.

Authors:  P J S Vig; J Wei; Q Shao; M D Hebert; S H Subramony; L T Sutton
Journal:  Neurosci Lett       Date:  2007-04-05       Impact factor: 3.046

Review 9.  New insight into transglutaminase 2 and link to neurodegenerative diseases.

Authors:  Boram Min; Kwang Chul Chung
Journal:  BMB Rep       Date:  2018-01       Impact factor: 4.778

10.  Molecular mechanism by which acyclic retinoid induces nuclear localization of transglutaminase 2 in human hepatocellular carcinoma cells.

Authors:  R Shrestha; H Tatsukawa; R Shrestha; N Ishibashi; T Matsuura; H Kagechika; S Kose; K Hitomi; N Imamoto; S Kojima
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.